Paper
Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms.
Published Jan 1, 2019 · M. Caldieraro, P. Cassano
Journal of affective disorders
79
Citations
3
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Systematic ReviewRigorous JournalHighly Cited
Study Snapshot
Non-retinal photobiomodulation shows potential as a novel treatment for major depressive disorder, with promising results in animal models and good tolerability.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···
Citations
—
···
—
···
—
···
—
···
—
···
—
···
—
···
—
···